reinhard

Master of Desaster :-)

Highlighting the relevance of chromosome 21 for childhood lymphoblastic leukemia

Chromosome 21 is the most affected chromosome in childhood acute lymphoblastic leukemia. Many of its numerical and structural abnormalities define diagnostically and clinically important subgroups. In their recent publication, investigators from St. Anna Children’s Cancer Research Institute, St. Anna Children’s Hospital and Labdia Labordiagnostik GmbH have now provided a comprehensive overview of all these types

Highlighting the relevance of chromosome 21 for childhood lymphoblastic leukemia Read More »

Top leukemia expert worldwide: Michael Dworzak

Top leukemia expert worldwide: Michael Dworzak awarded by independent ranking platform Developing new diagnostic methods for early detection and effective therapy of children and adolescents with leukemia – Univ.-Doz. Dr. Michael Dworzak’s research pursues goals that are vital for pediatric cancer patients. For his tireless efforts, he has now been honored by the international evaluation

Top leukemia expert worldwide: Michael Dworzak Read More »

The god of sun at the forefront of immunodeficiency-research

The god of sun at the forefront of immunodeficiency-research Scientists link mutations in the transcription factor Helios to a novel disease characterized by immunodeficiency and immune dysregulation. When scientists at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) identified an immune dysregulation caused by a biallelic germline mutation affecting Helios – a transcription factor

The god of sun at the forefront of immunodeficiency-research Read More »

Alternative method to animal testing for developing therapies

Tackling two tasks at once: Alternative method to animal testing for developing therapies against childhood cancer Congratulations to St. Anna Children’s Cancer Research Institute (St. Anna CCRI) scientists Univ. Prof. Dr. Heinrich Kovar and Dr. Branka Radic-Sarikas for winning a grant from the Austrian Science Fund (FWF) under the program “Alternative methods to animal testing”.

Alternative method to animal testing for developing therapies Read More »

Congrats to Davide Seruggia for receiving the ISTT Young Investigator Award!

ISTT Young Investigator Award 2021! The ISTT (International Society for Transgenic Technologies) Young Investigator Award identifies and recognizes young scientists who advance the science and technologies in the generation and analysis of transgenic animal models for biomedical research and biotechnology applications. Davide Seruggia received the award for his successful complex projects requiring advanced CRISPR technology:

Congrats to Davide Seruggia for receiving the ISTT Young Investigator Award! Read More »

OnTheTrack

St. Anna CCRI research project ONTHETRRAC honored as “success story”

The ONTHETRRAC research team discovered new aspects of tumor heterogeneity and developed tools that are important for accurate diagnosis, prognosis and for overcoming treatment resistance of the nerve tumor neuroblastoma in children. In the December newsletter 2021 its work was therefore honored as a “success story” by the research promotion network European Research Area (ERA-NET).

St. Anna CCRI research project ONTHETRRAC honored as “success story” Read More »

Decoding the epigenome and its regulation in neuroblastoma

New FWF-grant approved: Decoding the epigenome and its regulation in neuroblastoma CONGRATS to Irfete Fetahu, PhD, postdoc at St. Anna CCRI on receiving a Stand-Alone Grant from the Austrian Science fund FWF. Together with her PI Sabine-Taschner-Mandl from the Tumor Biology group and colleagues, Irfete has the ambitious goal to decode the epigenome and its

Decoding the epigenome and its regulation in neuroblastoma Read More »

Somatic Sex – the development of malignant diseases reinterpreted

Somatic Sex – the development of malignant diseases reinterpreted How do malignant diseases develop? In his recent publication, Oskar Haas from St. Anna Children’s Cancer Research Institute suggests that the unique chromosome patterns, which define specific tumor types, arise from an accidental fusion of two normal cells – a process that simulates the fertilization of

Somatic Sex – the development of malignant diseases reinterpreted Read More »

Executive board of Europe’s neuroblastoma network SIOPEN

Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN Developing new therapies for childhood nerve tumors and identifying more molecular markers for better diagnosis – this is what Sabine Taschner-Mandl strives for in her new role as Executive Committee Board Member of the European Neuroblastoma Research Group SIOPEN. Sabine Taschner-Mandl, PhD,

Executive board of Europe’s neuroblastoma network SIOPEN Read More »

EU Commissioner visits St. Anna

Childhood cancer is different from cancer in adults. Thus, it needs research specifically tailored to pediatric tumors, which requires dedicated funding. The need for medicines suitable for children, as well as improvements in long-term follow-up care for cancer survivors have been discussed with EU Health Commissioner Stella Kyriakides, M.Ed., and Austrian Health Minister Wolfgang Mückstein,

EU Commissioner visits St. Anna Read More »

Kaan Boztug awarded the “Işil Berat Barlan Award”

Kaan Boztug awarded the “Işil Berat Barlan Award for Primary Immunodeficiency Diseases” The scientist receives this award for his pioneering research on immunodeficiencies. Disturbances in the balance of the immune system can be the starting point for a number of diseases such as increased susceptibility to infections, autoimmune diseases and cancer. The study of congenital

Kaan Boztug awarded the “Işil Berat Barlan Award” Read More »